Chiung-Yuan Ko Selected Research

Transcription Factors (Transcription Factor)

11/2022	Inhibition of MZF1/c-MYC Axis by Cantharidin Impairs Cell Proliferation in Glioblastoma.
1/2021	CCAAT/Enhancer-binding protein delta mediates glioma stem-like cell enrichment and ATP-binding cassette transporter ABCA1 activation for temozolomide resistance in glioblastoma.
1/2018	Astrocytic CCAAT/Enhancer-binding protein delta contributes to reactive oxygen species formation in neuroinflammation.
11/2017	Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia.
11/2016	Astrocytic CCAAT/Enhancer-Binding Protein Delta Contributes to Glial Scar Formation and Impairs Functional Recovery After Spinal Cord Injury.
2/2015	Increase of zinc finger protein 179 in response to CCAAT/enhancer binding protein delta conferring an antiapoptotic effect in astrocytes of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiung-Yuan Ko Research Topics

Disease

15	Neoplasms (Cancer) 11/2022 - 11/2008
12	Glioblastoma (Glioblastoma Multiforme) 11/2022 - 10/2017
5	Glioma (Gliomas) 01/2021 - 11/2016
5	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2014
4	Inflammation (Inflammations) 01/2021 - 02/2012
4	Brain Neoplasms (Brain Tumor) 01/2021 - 04/2018
2	Spinal Cord Injuries (Spinal Cord Injury) 04/2023 - 11/2016
2	Leukemia 11/2017 - 02/2015
2	Amyloid Plaque 02/2015 - 01/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2010 - 11/2008
1	Cicatrix (Scar) 04/2023
1	Fibrosis (Cirrhosis) 11/2022
1	Lung Injury 11/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Astrocytoma (Pilocytic Astrocytoma) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Neuroinflammatory Diseases 01/2018
1	Infections 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Gliosis 11/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Liver Neoplasms (Liver Cancer) 11/2015
1	Hepatocellular Carcinoma (Hepatoma) 11/2008
1	Virus Diseases (Viral Diseases) 05/2002

Drug/Important Bio-Agent (IBA)

13	CCAAT-Enhancer-Binding Protein-deltaIBA 01/2022 - 11/2008
9	Temozolomide (Temodar)FDA LinkGeneric 03/2022 - 10/2017
6	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2014
6	Transcription Factors (Transcription Factor)IBA 11/2022 - 02/2015
4	Dehydroepiandrosterone (DHEA)IBA 01/2021 - 04/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2018
3	NeurosteroidsIBA 01/2021 - 04/2019
3	MethyltransferasesIBA 04/2019 - 11/2008
2	Peptides (Polypeptides)IBA 04/2023 - 01/2018
2	PTX3 proteinIBA 04/2023 - 11/2022
2	Glutathione PeroxidaseIBA 01/2022 - 01/2020
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 04/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2008
2	Vorinostat FDA Link 01/2021 - 11/2016
2	RNA (Ribonucleic Acid)IBA 04/2018 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2014
2	Messenger RNA (mRNA)IBA 01/2016 - 11/2008
1	Cantharidin (Cantharides)IBA 11/2022
1	CollagenIBA 11/2022
1	indium-bleomycinIBA 11/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2022
1	AntioxidantsIBA 01/2022
1	Pregnanolone (Allopregnanolone)IBA 01/2022
1	Superoxide DismutaseIBA 01/2022
1	CatalaseIBA 01/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022
1	EnzymesIBA 01/2022
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2021
1	Aromatase (CYP19)IBA 01/2021
1	Histone Deacetylase 6IBA 01/2021
1	MPT0B291IBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	AndrogensIBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	CurcuminIBA 01/2020
1	SteroidsIBA 09/2019
1	abirateroneIBA 09/2019
1	Hormones (Hormone)IBA 09/2019
1	NucleolinIBA 04/2018
1	Amyloid beta-PeptidesIBA 01/2018
1	Bortezomib (Velcade)FDA Link 11/2017
1	MicroRNAs (MicroRNA)IBA 11/2017
1	superoxide dismutase 2IBA 10/2017
1	CateninsIBA 01/2017
1	ClathrinIBA 01/2017
1	RNA IsoformsIBA 01/2017
1	Viral ProteinsIBA 01/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016
1	Decitabine FDA Link 11/2015
1	Thrombospondin 1IBA 03/2015
1	Promyelocytic Leukemia Zinc Finger ProteinIBA 02/2015
1	Insulin-Like Growth Factor Binding Protein 3IBA 02/2015
1	CytokinesIBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2014
1	Amino Acids FDA Link 05/2002
1	Glycoproteins (Glycoprotein)IBA 05/2002
1	glycoprotein 41IBA 05/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 12/2010
3	Radiotherapy 01/2021 - 04/2018
3	Drug Therapy (Chemotherapy) 01/2021 - 10/2017
1	Aftercare (After-Treatment) 01/2020
1	Transplantation 09/2019
1	CARE protocol 04/2018